Home » Topics » Disease categories and therapies » Ear, nose and throat

Ear, nose and throat
RSS

Initiation of phase I/II study of OTO-313 in patients with tinnitus

April 12, 2019

Frequency Therapeutics reports phase I/II data on FX-322 for hearing restoration

April 9, 2019

Hearing loss gene therapy works in adult mice

March 12, 2019

Novel dual AAV-mediated gene therapy shows efficacy in DFNB9 mouse model

Feb. 26, 2019

Positive results announced from phase I study of LY-3056480 in sensorineural hearing loss

Feb. 7, 2019

Sound Pharmaceuticals enrolls first patient in STOP Ototoxicity phase II study of SPI-1005

Jan. 15, 2019

Spiral Therapeutics initiates phase I trial of new hearing loss drug, LPT-99

Dec. 19, 2018

Seliforant shown not to affect vigilance, cognitive performance during motion stimulus

Dec. 14, 2018

Novus initiates phase I trial of OP-0201 for otitis media

Nov. 29, 2018

Sensorion signs letter of intent with Institut Pasteur for hearing loss gene therapy programs

Nov. 23, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...